Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-11-22 4:46 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner | 0 | $0 | 1,220,502 (Indirect) | View |
| 2022-07-26 Other | 2022-07-28 9:23 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | E&Investment Inc. E&Healthcare Investment Fund II 10% Owner | 1,445,267 | $0 | 7,461,936 (Indirect) | View |
| 2022-07-26 Other | 2022-07-28 4:03 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 1,445,267 | $0 | 7,365,585 (Indirect) | View |
| 2022-06-09 Option Award | 2022-06-13 4:14 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:12 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:28 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Hyung Heon Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:25 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | Kang Richard Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:23 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:22 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:21 pm | N/A 2032-06-09 | NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-02-02 5:51 pm | N/A 2032-01-27 | NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-11-03 Option Award | 2021-11-04 4:57 pm | N/A 2031-11-03 | NeuroBo Pharmaceuticals Inc. | NRBO | Price Ben Gil CEO and President | 616,666 | $0 | 616,666 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 11:43 am | N/A 2031-09-01 | NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 4:09 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Bakshi Akash SVP and COO | 884,072 | $0 | 913,085 (Direct) | View |
| 2020-09-01 Option Award | 2020-09-03 6:48 pm | N/A 2030-09-01 | NeuroBo Pharmaceuticals Inc. | NRBO | Swirsky Douglas J Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership(A) | 2020-01-17 2:34 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | JK BioPharma Solutions Inc Kang Sun Dae 10% Owner | 0 | $0 | 2,618,012 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:16 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:15 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Oh Jeong Gyun Director 10% Owner | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:13 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:12 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Jeong Tae Heum Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:11 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Gullans Steven R. Ph.D. Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:10 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership(A) | 2020-01-10 6:11 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | E&Investment Inc. E&Healthcare Investment Fund II E&Healthcare Investment Fund No.7 10% Owner | 0 | $0 | 7,321,789 (Indirect) | View |
Ownership | 2020-01-09 9:28 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | JK BioPharma Solutions Inc 10% Owner | 0 | $0 | 2,618,012 (Direct) | View |
Ownership | 2020-01-09 9:27 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | E&Investment Inc. 10% Owner | 0 | $0 | 7,321,789 (Indirect) | View |
Ownership | 2020-01-09 4:29 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner | 0 | $0 | 2,880,612 (Direct) | View |
| 2019-12-30 Option Award | 2020-01-02 9:54 pm | N/A 2029-01-28 | NeuroBo Pharmaceuticals Inc. | NRBO | Versavel Mark Chief Medical Officer | 342,930 | $0 | 342,930 (Direct) | View |
| 2019-12-30 Option Award | 2020-01-02 9:53 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Oh Jeong Gyun Director 10% Owner | 2,057,893 | $0 | 240,051 (Indirect) | View |
| 2019-12-30 Option Award | 2020-01-02 9:52 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 7,321,789 | $0 | 1,864,799 (Indirect) | View |